BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7709364)

  • 1. Congenital malformations in the offspring of male mice treated with ethylnitrosourea at the embryonic stage.
    Wada A; Sato M; Takashima H; Nagao T
    Teratog Carcinog Mutagen; 1994; 14(6):271-9. PubMed ID: 7709364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male-mediated teratogenesis: spectrum of congenital malformations in the offspring of A/J male mice treated with ethylnitrosourea.
    Nagao T; Fujikawa K
    Teratog Carcinog Mutagen; 1996; 16(6):301-5. PubMed ID: 9178452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular development and fertility of mice treated prenatally with N-nitroso-N-ethylurea at various gestational stages.
    Nagao T; Sato M; Marumo H; Shibuya T; Imai K
    Teratog Carcinog Mutagen; 1996; 16(3):183-98. PubMed ID: 8983120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital defects in the offspring of male mice treated with ethylnitrosourea.
    Nagao T
    Mutat Res; 1988 Nov; 202(1):25-33. PubMed ID: 3185593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of recessive mutations in mouse primordial germ cells with N-ethyl-N-nitrosourea.
    Shibuya T; Murota T; Horiya N; Matsuda H; Hara T
    Mutat Res; 1993 Dec; 290(2):273-80. PubMed ID: 7694119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic potency in mouse spermatogonial stem cells of triethylenemelamine, mitomycin C, ethylnitrosourea, procarbazine, and propyl methanesulfonate as measured by F1 congenital defects.
    Nagao T; Fujikawa K
    Mutat Res; 1990 Apr; 229(2):123-8. PubMed ID: 2157148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethylnitrosourea-induced apoptosis in primordial germ cells of the rat fetus.
    Katayama K; Ueno M; Yamauchi H; Nakayama H; Doi K
    Exp Toxicol Pathol; 2002 Nov; 54(3):193-6. PubMed ID: 12484555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for transgenerational genomic instability in the F1 or F2 descendants of Muta™Mouse males exposed to N-ethyl-N-nitrosourea.
    O'Brien JM; Williams A; Gingerich J; Douglas GR; Marchetti F; Yauk CL
    Mutat Res; 2013; 741-742():11-7. PubMed ID: 23499255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of respiratory distress and chromosomal abnormalities in the offspring of male mice treated with ethylnitrosourea.
    Nomura T; Gotoh H; Namba T
    Mutat Res; 1990 Apr; 229(2):115-22. PubMed ID: 2320024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratologic studies on rat perinates and offspring from dams treated with ethylnitrosourea (ENU).
    Katayama K; Ishigami N; Suzuki M; Ohtsuka R; Kiatipattanasakul W; Nakayama H; Doi K
    Exp Anim; 2000 Jul; 49(3):181-7. PubMed ID: 11109540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-alkyl-N-nitrosourea induced secondary structural changes in DNA from rat embryos and fetal brains in vivo.
    Huang PH; Catalano A
    Teratog Carcinog Mutagen; 1992; 12(3):135-53. PubMed ID: 1363003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal development and neoplastic disease pattern in NMRI mice after combined treatment with ethylnitrosourea and X-irradiation on different days of the fetal period.
    Wiggenhauser A; Schmahl W
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jun; 51(6):1021-9. PubMed ID: 3496295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethylnitrosourea induces apoptosis and growth arrest in the trophoblastic cells of rat placenta.
    Katayama K; Ueno M; Takai H; Ejiri N; Uetsuka K; Nakayama H; Doi K
    Biol Reprod; 2002 Aug; 67(2):431-5. PubMed ID: 12135877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of a single AT basepair in mice transgenic for PhiX174 am3, cs70. II. Brain.
    Malling HV; Newbold RR; Lewis S; Barnett L; Weaver RP
    Mutat Res; 1999 Jul; 444(1):85-95. PubMed ID: 10477342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.
    Charles DJ; Pretsch W
    Mutat Res; 1987 Jan; 176(1):81-91. PubMed ID: 3796661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-associated immunopotentiation affects the embryo response to teratogens.
    Torchinsky A; Fein A; Carp HJ; Toder V
    Clin Exp Immunol; 1994 Dec; 98(3):513-9. PubMed ID: 7994915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism of congenital malformations induced by exposure of mouse preimplantation embryos to mitomycin C.
    Nagao T; Saitoh Y; Yoshimura S
    Teratology; 2000 Apr; 61(4):248-61. PubMed ID: 10716743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of congenital malformations in the offspring of mutagen treated mice.
    Lyon MF; Renshaw R
    Prog Clin Biol Res; 1986; 209B():449-58. PubMed ID: 3749099
    [No Abstract]   [Full Text] [Related]  

  • 19. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of forward and reverse specific-locus mutations and dominant cataract mutations in spermatogonia of treated strain DBA/2 mice by ethylnitrosourea.
    Favor J; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1991 Aug; 249(2):293-300. PubMed ID: 2072972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.